Subscribe to Newsletter

Oncology

Subspecialties Histology

Molecular Drivers of Mesothelioma

| Stefania Erra, Carolina Pelazza

A case series that explores the potential molecular contributors to pleural mesothelioma carcinogenesis – and its treatment options

Subspecialties Oncology

Beating the Biopsy

| Michael Schubert

A new approach to prostate cancer testing aims to decrease unnecessary biopsies and reduce over-treatment

Diagnostics Genetics and epigenetics

On NTRK and Other Fusion Biomarkers

| Fernando Lopez-Rios

Next-generation sequencing is changing the future of precision oncology with its ability to test for NTRK gene fusions and more

Diagnostics Precision medicine

Deep Bio’s Deep Dive

| Sponsored by Deep Bio

AI diagnostics offer great potential for the future – and as a disease of many challenges, prostate cancer is a great first target

Inside the Lab Precision medicine

The Next Generation of Variant Profiling

| Anoop Grewal

In-depth analysis of next-generation sequencing can help personalize cancer treatment and drive the adoption of precision medicine

Subspecialties Cytology

A Better Future for Bladder Cancer

| John Cucci

A new immunocytochemistry stain offers a sensitive, noninvasive, and cost-effective diagnostic tool for patients at risk of bladder cancer

Subspecialties Cytology

Protecting Patients from Progression

| Michael Schubert

A new molecular test offers the first opportunity to identify the patients who are most likely to benefit from treatment, rather than surveillance

Diagnostics Companion diagnostics

What Would Your Oncologist Think If…

| Roberto Salgado

Not every assay that trials well is practical for implementation in daily practice. How can we tell which ones are, and whose responsibility is it?

Inside the Lab Technology and innovation

Quick Hits

| Luke Turner

Discover the latest in pathology and laboratory medicine with this roundup of short news stories

Inside the Lab Precision medicine

All the RAGE

| Luke Turner

A new genomic barcode tracker could help spot the rare immune cells that are most effective against cancer

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register